Position in NVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$249,572,092
+$58,125,650 QoQ
Shares Held
5,205,926
-0.1% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#16
of 1,341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital World Investors holds $50,250,725,849 across 10 Drug Manufacturers - General names. NVO ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,902,642 | $19,074,107,484 | |
| 2 | AMGN |
Amgen Inc
|
29,075,329 | $10,528,758,137 | |
| 3 | AZN |
Astrazeneca PLC
|
30,075,134 | $5,702,846,909 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
40,988,975 | $5,178,547,101 | |
| 5 | ABBV |
AbbVie Inc.
|
19,178,966 | $4,826,195,004 | |
| 6 | JNJ |
Johnson & Johnson
|
15,215,015 | $3,864,157,359 | |
| 7 | PFE |
Pfizer Inc
|
22,218,190 | $535,014,015 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
5,205,926 | $249,572,092 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $249,572,092 | 5,205,926 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $191,446,442 | 5,209,427 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,143,589 | 199,363 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $11,700,732 | 210,862 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $14,886,647 | 215,686 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $14,427,548 | 207,770 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $382,446,554 | 4,446,019 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $530,339,685 | 4,454,016 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $637,174,944 | 4,463,885 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $504,409,384 | 3,928,422 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $410,843,088 | 3,971,417 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $360,700,596 | 3,966,358 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $320,747,221 | 1,982,001 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $278,949,662 | 1,752,857 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $189,352,434 | 1,399,087 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $72,643,421 | 729,132 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,079,563 | 36,611 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,993,469 | 35,961 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $3,776,864 | 33,722 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,967,285 | 30,906 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,518,209 | 30,061 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,874,343 | 27,801 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,621,008 | 23,207 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,386,933 | 19,976 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,234,756 | 18,857 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $764,660 | 12,702 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||